Immunotherapy has an established role in the treatment of advanced non–small cell lung cancer (NSCLC) and a growing role in the approach to earlier......READ MORE
Immuno-oncology has transformed the treatment paradigm across multiple tumor types and histologies. Proceedings from the 2022 ASCO Annual Meeting h......READ MORE
At the 2022 ASCO Annual Meeting, several studies highlighted the promise of combination strategies and the optimal incorporation of immune checkpoi......READ MORE
Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, ......READ MORE
conference reporter by Christopher J. Logothetis, MD
Research focusing on new targeting strategies for metastatic castration-resistant prostate cancer (mCRPC) is burgeoning, as reflected by the procee......READ MORE
conference reporter by Christopher J. Logothetis, MD
An analysis shared at the 2022 Genitourinary Cancers Symposium highlights the importance of considering a patient's treatment preferences and quali......READ MORE
